Ona Therapeutics Completes $86.6 Million Series B Financing

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised Ona Therapeutics. Ona Therapeutics, a biopharmaceutical company focused on pioneering antibody-drug conjugates (ADCs) for treatment-resistant cancers, has announced the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here